| Mouse models of prostate cancer: picking the best model for the question MM Grabowska, DJ DeGraff, X Yu, RJ Jin, Z Chen, AD Borowsky, ... Cancer and Metastasis Reviews 33, 377-397, 2014 | 121 | 2014 |
| Soluble E-cadherin: more than a symptom of disease MM Grabowska, ML Day Frontiers in bioscience (Landmark edition) 17, 1948, 2012 | 112 | 2012 |
| NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression MM Grabowska, AD Elliott, DJ DeGraff, PD Anderson, G Anumanthan, ... Molecular endocrinology 28 (6), 949-964, 2014 | 77 | 2014 |
| Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer OL Reddy, JM Cates, LL Gellert, HS Crist, Z Yang, H Yamashita, ... The American journal of pathology 185 (5), 1385-1395, 2015 | 70 | 2015 |
| NF‐κB and androgen receptor variant expression correlate with human BPH progression DC Austin, DW Strand, HL Love, OE Franco, A Jang, MM Grabowska, ... The Prostate 76 (5), 491-511, 2016 | 59 | 2016 |
| EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells MM Grabowska, B Sandhu, ML Day Cellular signalling 24 (2), 532-538, 2012 | 57 | 2012 |
| SOX2 expression in the developing, adult, as well as, diseased prostate X Yu, JM Cates, C Morrissey, C You, MM Grabowska, J Zhang, ... Prostate cancer and prostatic diseases 17 (4), 301-309, 2014 | 53 | 2014 |
| FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype DJ DeGraff, MM Grabowska, TC Case, X Yu, MK Herrick, WJ Hayward, ... Laboratory investigation 94 (7), 726-739, 2014 | 47 | 2014 |
| NF‐κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance DC Austin, DW Strand, HL Love, OE Franco, MM Grabowska, NL Miller, ... The Prostate 76 (11), 1004-1018, 2016 | 26 | 2016 |
| Nfib regulates transcriptional networks that control the development of prostatic hyperplasia MM Grabowska, SM Kelly, AL Reese, JM Cates, TC Case, J Zhang, ... Endocrinology 157 (3), 1094-1109, 2016 | 24 | 2016 |
| Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia P Popovics, WN Awadallah, SE Kohrt, TC Case, NL Miller, EA Ricke, ... The Prostate 80 (10), 731-741, 2020 | 23 | 2020 |
| Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro SE Kohrt, WN Awadallah, RA Phillips III, TC Case, R Jin, JS Nanda, X Yu, ... Molecular cancer therapeutics 20 (2), 398-409, 2021 | 19 | 2021 |
| Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression J Qiao, MM Grabowska, IS Forestier, J Mirosevich, TC Case, DH Chung, ... Oncotarget 7 (38), 61955, 2016 | 19 | 2016 |
| Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo S Yang, M Jiang, MM Grabowska, J Li, ZM Connelly, J Zhang, ... Oncotarget 7 (43), 70404, 2016 | 15 | 2016 |
| Increased nuclear factor I/B expression in prostate cancer correlates with AR expression JS Nanda, WN Awadallah, SE Kohrt, P Popovics, JMM Cates, ... bioRxiv, 684472, 2020 | 9 | 2020 |
| SLX4IP promotes telomere maintenance in androgen receptor–independent castration-resistant prostate cancer through ALT-like telomeric PML localization TL Mangosh, WN Awadallah, MM Grabowska, DJ Taylor Molecular Cancer Research 19 (2), 301-316, 2021 | 7 | 2021 |
| Microbial metabolites of flavanols in urine are associated with enhanced anti-proliferative activity in bladder cancer cells in vitro LE Griffin, SE Kohrt, A Rathore, CD Kay, MM Grabowska, AP Neilson Nutrition and cancer 74 (1), 194-210, 2022 | 5 | 2022 |
| Therapy-induced small-cell disease: From mouse to man and back MM Grabowska, RJ Matusik Nature Reviews Urology 15 (11), 662-663, 2018 | 3 | 2018 |
| SLX4IP N‐terminus dictates telomeric localization in ALT‐like castration‐resistant prostate cancer cell lines TL Mangosh, MM Grabowska, DJ Taylor The Prostate 81 (15), 1235-1251, 2021 | 1 | 2021 |
| IL1B loss is associated with increased AR activity in castration-resistant prostate cancer WN Awadallah, JS Nanda, SE Kohrt, MM Grabowska bioRxiv, 2021.08. 31.458406, 2021 | | 2021 |
Robert J. MatusikVanderbilt University Medical CenterVerified email at Vanderbilt.Edu
